scholarly journals COVID-19 CORONA VIRUS PANDEMIC: Challenges and Managerial Strategies for Hospital as Isolation Center with special reference to Jagadguru Dattatray Hospital & Research Center, Indore.

2020 ◽  
Vol 4 (6) ◽  
pp. 10-14
Author(s):  
Suyog S Dekhne ◽  
Ankita Ratnaparkhi Dekhne
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Virus Disease ◽  
Health Department ◽  
Research Center ◽  
Private Hospitals ◽  
Corona Virus ◽  
First Case ◽  
The World ◽  
Managerial Strategies ◽  
Hospital Research

SARS CoV-2 i.e. Severe Acute Respiratory Syndrome Corona Virus-2 is the cause for spread of contagious COVID-19 (Corona Virus Disease-2019) in the world. According to resources, bats are the main source for SARS-CoV-2 communication, although the virus might have jumped from another transitional host to humans. COVID-19 was first diagnosed in Wuhan, China during end of December 2019 and has since increased progressively resulting in the current corona virus pandemic. The first case of COVID-19 in India was observed on 30th January 2020. Whereas the first case of COVID-19 in Indore (MP) was reported on 23rd March 2020 and since then it is increasing rapidly resulting in scores of casualties. Before the arrival of pandemic, Indore Administrative Department, Municipal Corporation, Health Department in co-operation with private hospitals were prepared to face the change. Jagadguru Dattatray Hospital & Research Center, Indore was one of the CDCP (Center for Disease Control & Prevention) and Isolation Centers in Indore. This paper highlights the challenges and strategies adopted by a hospital as an isolation center to fight against a world spread pandemic i.e. COVID-19.

Coronavirus and Fingerprint Technology

2021 ◽  
Vol 13 (4) ◽  
pp. 1-16
Author(s):  
Gabriel B. Iwasokun
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Viral Infection ◽  
Virus Disease ◽  
High Rate ◽  
Corona Virus ◽  
The World ◽  
Almost All

The corona virus disease, otherwise known as COVID-19, is an extremely communicable and pathogenic viral infection caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), which emerged in Wuhan, China in December 2019 and has spread to almost all the countries in the world. The transmission of the virus is through touching of the nose, eyes, or mouth by a finger that has been contaminated through droplets on a surface when a carrier sneezes or coughs. Since the existing fingerprint devices are predominantly contact based, it implies that they can aid in the transmission of the virus. This paper discusses the application of fingerprint devices in notable places with high rate of COVID-19 infection as well as the threats to fingerprint technologies and the countermeasures. The need to change focus and orientation towards contactless biometric technologies as sure solution to the fear and animosity expressed towards contact-based fingerprint technology is also expatiated.

scholarly journals Novel immunogenomic insights of corona virus disease (COVID-19): Available potential immunotherapeutics, current challenges, immune cell recognition and ongoing managerial strategies

2020 ◽  
Vol 7 (8) ◽  
pp. 3906-3915
Author(s):  
Kabeer Haneef ◽  
Muhammad Umer Asghar ◽  
Ashiq Ali
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Virus Strain ◽  
Immune Cell ◽  
Virus Disease ◽  
Adaptive Immune System ◽  
Antiviral Drugs ◽  
Corona Virus ◽  
Wide Range ◽  
Managerial Strategies ◽  
Spread Of Infection

The emerging Corona virus strain (severe acute respiratory syndrome corona virus-2 (SARS-CoV-2)) harbors intricate in the development of corona virus infection (COVID-19)-induced pneumonia and subsequently ameliorates lung infection. Genome sequence and interventions reveal proximal resemblance of corona virus strain COVID-19 with severe acute respiratory syndrome (SARS), transmittable to bats, suggesting similar primary hosts in the spread of infection. However, potential rapid human-to-human transmission has caused therapeutic challenges in treating a wide range of humans suffering from corona virus all over the world. However, up to now, no direct vaccines or antiviral drugs are available to treat COVID-19. Previously designed antiviral drugs and convalescent plasma are undergoing investigations as treatment for COVID-19 infected patients. Therapeutic challenges with regards to COVID-19 have prompted scientists to develop fruitful remedies to combat the pathogen. In this review, we address the role of current ongoing therapeutic strategies, , and complex mechanisms of adaptive immune system (B and T cells) to respond to viruses. Furthermore, we illustrate the current challenges in the treatment of COVID-19, managerial strategies, and ongoing and future perspectives.

scholarly journals The First Case of Reactive Arthritis Associated with SARS-CoV-2-Infection in A 4-Year Old Child

2020 ◽  
Author(s):  
Stephanie Gabriele Werner ◽  
Hans-Eckhard Langer
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Reactive Arthritis ◽  
Virus Disease ◽  
The Novel ◽  
Case Presentation ◽  
Corona Virus ◽  
First Case ◽  
Novel Coronavirus ◽  
The Right

Abstract Background: The novel coronavirus SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2) and its associated disease COVID‐19 (Corona Virus Disease 19) has become a worldwide pandemic since its first cases in December 2019 in Wuhan Province in China. In Germany the pandemic started in February 2020.Case presentation: A 4 year old boy was presented and suffered from pain in the right hip. Arthrosonography demonstrated a significant effusion in the involved joint. The extended history revealed a slight but long lasting cold before. Serological findings were inconspicuous except for positive ELISA (Enzyme-linked Immuno Sorbent Assay) - test for SARS-CoV-2. Conclusion: In conclusion we believe that we can report the first case of reactive arthritis associated with SARS-CoV-2 in children.

scholarly journals COVID-19: an Indian perspective

2020 ◽  
Vol 7 (5) ◽  
pp. 2003
Author(s):  
Prahlad Kadambi
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Index Case ◽  
World Health ◽  
Corona Virus ◽  
First Case ◽  
The World ◽  
Health Organization ◽  
The University ◽  
Indian Perspective

Severe acute respiratory syndrome coronavirus 2 is currently spreading globally rapidly. The World Health Organization (WHO) named the virus as the 2019 novel corona virus (2019-nCoV) on January 7, 2020. On February 11th 2020, the illness associated was named as 2019 coronavirus disease (COVID-19). Subsequently, the WHO declared COVID-19 as a pandemic on 11 March 2020. The first case of COVID-19 was reported in India on 30 January 2020 in Thrissur, Kerala. This was the index case in India who tested positive after coming for a vacation. This individual was a student of the University of Wuhan. Subsequent cases were reported in Kerala. Subsequently, the number of cases in India increased to 519 as on 24th March 2020 with mortality in 7 patients as on 22nd March 2020 and 10 patients on 24th March 2020.

scholarly journals Loss of Smell and Taste: Potential of Using Them as Markers for Early Detection of Covid-19

2020 ◽  
Vol 3 (2) ◽  
Keyword(s):  
Early Detection ◽  
Severe Acute Respiratory Syndrome ◽  
Virus Disease ◽  
Age Groups ◽  
Viral Disease ◽  
Human Race ◽  
Health Crisis ◽  
Corona Virus ◽  
The World

The world is currently witnessing a severe health crisis of its time. Everyone is juggling and struggling to fight a viral disease named Covid-19 (Corona virus disease 2019) caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). The genome of newly identified virus is less than 30,000 letters long where pathogenesis involve from being asymptomatic to deadly in all age groups. Almost everybody is at a grave risk in such an unpredictable scenario where range of symptoms are so variable from people to people making this pandemic a threat to human race.

scholarly journals Literature Review of Epidemiological Phenomena: Corona Virus Disease Pandemic 2019

2020 ◽  
Vol 2 (3) ◽  
Author(s):  
Yarmaliza Yarmaliza ◽  
Teungku Nih Farisni ◽  
Fitriani Fitriani ◽  
Zakiyuddin Zakiyuddin ◽  
Fitrah Reynaldi ◽  
...  
Keyword(s):  
Virus Infection ◽  
Severe Acute Respiratory Syndrome ◽  
Literature Review ◽  
Virus Disease ◽  
Wuhan City ◽  
Corona Virus ◽  
The World ◽  
History Of ◽  
New Type ◽  
The City

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or Corona virus is a new type of coronavirus that is transmitted to humans. Corona virus infection called COVID-19 (Corona Virus Disease 2019) was first discovered in the city of Wuhan, China at the end of December 2019. Until March 2, 2020, more than 80 thousand confirmed cases have been reported in China. Of these cases, 49 thousand were identified in Wuhan City. Epidemiologically, the spread or distribution of this disease has a wide social and economic impact on the world. Many literature studies about the COVID-19 outbreak, such as causes, natural history of the disease, even to the preventive and medical treatment. Since the end of 2019 until April 2020, there have been many published literature or literature studies at both national and international levels, so this paper aims to examine literature studies related to COVID-19.

Covid-19, SARS -CoV-2, Origin, transmission and treatment aspects, a brief review

2020 ◽  
Vol 20 ◽  
Author(s):  
Shahid Nawaz
Keyword(s):  
Mortality Rate ◽  
Severe Acute Respiratory Syndrome ◽  
Clinical Manifestation ◽  
Virus Disease ◽  
The Novel ◽  
Research Activities ◽  
Corona Virus ◽  
Global Pandemic ◽  
The World

: The emergence of severe acute respiratory syndrome (SARS) in Wuhan (china) named as corona virus disease 19(covid-19) caused by the novel corona virus SARS-CoV-2 has caused hundreds of thousands of mortalities across the world ,while the mortality rate is in millions, leading it to be declared as a global pandemic. Numerous research activities are undergoing to reveal the disease and etiological features of covid-19. In this review, some of the interesting aspects of covid-19 are discussed, that includes, the origin of the SARS-CoV-2, clinical manifestation, treatment and future aspects of the disease.

scholarly journals Corona kills corona: convalescent sera option for global war against corona virus disease 2019

2020 ◽  
Vol 7 (5) ◽  
pp. 2001
Author(s):  
Babita . ◽  
Anita Punia ◽  
S. K. Jha ◽  
Mahavir Jangra
Keyword(s):  
Nucleic Acid ◽  
Severe Acute Respiratory Syndrome ◽  
Virus Disease ◽  
Hubei Province ◽  
Atypical Pneumonia ◽  
Corona Virus ◽  
First Case ◽  
Rna Genome ◽  
Global War ◽  
Nucleic Acid Tests

On December 31st, 2019 China reported first case of atypical pneumonia in Wuhan, the capital of Hubei province. The causative virus was found to be a beta coronavirus, closely related to the severe acute respiratory syndrome coronavirus (SARS-CoV-1) from 2003 and similar to Sarbeco viruses isolated from bats. It was therefore termed SARS-CoV-2 and the disease was named corona virus disease 2019 (COVID-19). The outbreak in Wuhan expanded quickly and led to the lockdown of Wuhan and other parts of China. While the lockdown, at least temporarily, brought the situation under control in China, but SARS-CoV-2 spread globally causing a pandemic with more than 4 lakh infections and about 19000 fatalities (as of March 25, 2020). Nucleic acid tests that detect the SARS-CoV-2 RNA genome were quickly developed and are now widely employed to diagnose COVID-19.

COVID-19

2022 ◽  
pp. 1-16
Author(s):  
Soraia El Baz ◽  
My Abdelmonaim El Hidan ◽  
Nadia Zouhairi ◽  
Abdelmohcine Aimrane ◽  
Redouane Chatoui ◽  
...  
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Current Knowledge ◽  
Virus Disease ◽  
Case Fatality ◽  
Unknown Etiology ◽  
Human Coronavirus ◽  
Corona Virus ◽  
The World ◽  
Human Coronaviruses

Since December 2019, a pneumonia outbreak with unknown etiology occurred in Wuhan, China. Later, the pathogen was identified as novel human coronavirus and named as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The disease was named corona virus disease 2019 (COVID-19) and caused a pandemic. As of 23 June 2020, the global COVID-19 pandemic has battered the world. More than 1.5 million people have died with over 80 million people confirmed infected. This outbreak is spreading in approximately 216 countries and regions as of 22 July 2020. Comparing the three human coronavirus, SARS and MERS have significantly higher case fatality rates than COVID-19, but COVID-19 is more infectious and spreads more easily among people. Therefore, in this chapter, the authors summarize the most fatal pandemic in recorded history. Also, they collected all information about the current knowledge about COVID-19 pandemic including similarity and differences with other human coronaviruses.

scholarly journals COVID-19 in Africa: rethinking the tools to manage future pandemics

2021 ◽  
Vol 21 (4) ◽  
pp. 1509-17
Author(s):  
Ismaila Emahi ◽  
Mimmie CNC Watts ◽  
Samuel Azibere ◽  
Joseph F Morrison ◽  
Kwabena AN Sarpong
Keyword(s):  
Public Health ◽  
Severe Acute Respiratory Syndrome ◽  
Virus Disease ◽  
World Health ◽  
Corona Virus ◽  
Preventative Health ◽  
The World ◽  
Health Organization ◽  
Science Leadership ◽  
Low Rate

Corona virus disease 2019 (COVID-19) remains an incurable, progressive pneumonia-like illness characterized by fever, dry cough, fatigue, and headache during its early stages. COVID-19 has ultimately resulted in mortality in at least 2 million people worldwide. Millions of people globally have already been affected by this disease, and the numbers are expected to increase, perhaps until an effective cure or vaccine is identified.Although Africa was initially purported by the World Health Organization (WHO) to be severely hit by the pandemic, Africa recorded the least number of cases during the first wave, with lowest rates of infections, compared to Asia, Europe, and the Americas. This statistic might be attributed to the low testing capacity, existing public health awareness and lessons learnt during Ebola epidemic. Nonetheless, the relatively low rate of infection should be an opportunity for Africa to be better prepared to overcome this and future epidemics.In this paper, the authors provide insights into the dynamics and transmission of the severe acute respiratory syndrome corona virus (SARS-CoV-2) during the first wave of the pandemic; possible explanations into the relatively low rates of infection recorded in Africa; with recommendations for Africa to continue to fight Covid-19; and position itself to effectively manage future pandemics. Keywords: Covid-19; Ebola; Science Leadership in Africa; Vaccine; SARS-COV-2; Preventative Health; Future Pandemics.

Sign in / Sign up

Export Citation Format

Share Document